ABT vs RVTY
Abbott Laboratories (ABT) and Revvity (RVTY) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $17.7B for Revvity, about 10.1 times the size. On trailing earnings, ABT is cheaper at 38.6x versus 76.0x for RVTY.
Head to head
| Metric | ABT | RVTY |
|---|---|---|
| Market cap | $179.4B | $17.7B |
| P/E (TTM) | 38.6x | 76.0x |
| Forward P/E | 17.4x | 26.9x |
| Revenue (TTM) | $48.2B | — |
| Revenue growth | 14.5% | — |
| Gross margin | 57.1% | — |
| Operating margin | 11.3% | — |
| Free cash flow | $7.4B | $558.1M |
| Dividend yield | 2.43% | 0.18% |
| 1-year return | -15.9% | +63.1% |
| 5-year return (annual) | -2.0% | -1.8% |
| Max drawdown | -46% | -92% |
| FI Handbook grade | C+ | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs RVTY FAQ
Which is bigger, ABT or RVTY?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $17.7B for Revvity, about 10.1 times the size.
Is ABT or RVTY cheaper?
On trailing earnings, ABT is cheaper at 38.6x versus 76.0x for RVTY. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or RVTY?
RVTY returned +63.1% over the past year including dividends, versus -15.9% for ABT, through October 23, 2026.
Which pays a higher dividend, ABT or RVTY?
ABT yields 2.43% versus 0.18% for RVTY.
Full pages: Abbott Laboratories · Revvity